Empowered Funds, LLC Exelixis, Inc. Transaction History

Empowered Funds, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2017 Feb 01, 2018	SELL	$24.23 - $30.93 $636,352 - $812,314	-26,263 Closed	0 $0
Q3 2017 Jul 09, 2018	BUY	$23.35 - $29.24 $613,241 - $767,930	26,263 New	26,263 $636,000
Q3 2017 Oct 31, 2017	SELL	$23.35 - $29.24 $780,473 - $977,347	-33,425 Closed	0 $0
Q2 2017 Jul 09, 2018	BUY	N/A	33,425 New	33,425 $823,000
Q2 2017 Aug 08, 2017	SELL	N/A	-31,416 Closed	0 $0
Q1 2017 Jul 09, 2018	BUY	N/A	31,416	31,416 $681,000

503

244M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.7B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Empowered Funds, LLC, based on Form 13F filings with the SEC.

Stay updated on Empowered Funds, LLC with notifications on news.